why choose us

Clinical Trials Search

Showing 6,700 of 132,085 result(s)
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF): A Type 1 Hybrid Effectiveness- Implementation Trial

Status: NOT_YET_RECRUITING

Condition: Heart Failure

Interventions: I-TRANSFER-HF is comprised of early and intensive HHC nurse visits and an outpatient visit within 7 days of discharge.
Using a Hybrid Type 1, ste

Date: 2023-10-31

EKO SENSORA: Detecting Clinically Significant Murmurs

Status: Completed

Condition: Heart Murmurs

Interventions: The exam involves placing the stethoscope in the aortic, pulmonic, tricuspid, and mitral areas for 15-30 seconds until a green light is displayed indi

Date: 2023-10-31

A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Status: NOT_YET_RECRUITING

Condition: Neovascular Age-Related Macular Degeneration (nAMD)

Interventions: KHK4951 eye drop for 44 weeks until end of the trial

Date: 2023-10-31

Developing and Testing a Nurse-Led Technology-Enhanced Family Engagement Program

Status: NOT_YET_RECRUITING

Condition: Critical Illness

Interventions: PFCC-IR with the critical care team is standard practice in ICU but it doesn't usually include family members.
The intervention for this stu

Date: 2023-10-31

MISHA™ Post-Market Clinical Study

Status: Completed

Condition: Osteo Arthritis Knee

Interventions: The MISHA Knee System is an extra-capsular knee implant intended to reduce loads on the medial knee.
The implant consists of an absorber located

Date: 2023-10-31

Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With Subarachnoid Hemorrhage

Status: NOT_YET_RECRUITING

Condition: Subarachnoid Hemorrhage, Aneurysmal

Interventions: Telavancin 10mg;kg (maximum 1000mg) administered intravenously over 60 minutes (through a central venous catheter whenever available).

Date: 2023-10-31

Utilizing Battlefield Acupuncture to Treat Chronic Pain

Status: NOT_YET_RECRUITING

Condition: Chronic Pain

Interventions: 5 points of acupuncture treatment in each ear weekly for 8 weeks

Date: 2023-10-31

An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

Status: Completed

Condition: Unresectable Hepatocellular Carcinoma

Interventions: Atezolizumab combined with Bevacizumab, immune checkpoint inhibitors combination.

Date: 2023-10-31

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Status: COMPLETED

Condition: AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs

Interventions: anti-vascular endothelial growth factor monoclonal antibody drug includes bevacizumab;

Date: 2023-10-31

Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy

Status: COMPLETED

Condition: Aromatherapy

Interventions: Aromatherapy is a TAT (Tapas Acupressure technique) method in which essential oils created from fragrant parts of plants are absorbed from the body an

Date: 2023-10-31